We are thrilled to announce a major milestone at 3DNanoscopy—our recent funding success for our groundbreaking in vitro screening platform, Cymoplive. A special congratulations to Biswajoy Ghosh, the principle investigator on this project. As a dedicated team at the forefront of cancer research, we are driven by our commitment to innovate and improve the tools available in cancer therapy.
Our Innovative Platform Cymoplive is built upon a robust scientific proof of concept and the platform stands ready to take significant strides toward market readiness. This technology not only promises to enhance the efficacy of screening cancer drugs but also aims to tackle the drugs that typically encounter low success rates in clinical trials.
Objectives and Goals With the fresh infusion of funds, our objectives are clear:
- Develop a Product Proof of Concept – Transitioning from a scientific to a product proof of concept, making our results more tangible and applicable.
- Engage Early Beta Testers – Collaborate with early adopters in the oncology field to test and refine our platform based on real-world data and feedback.
- Market Feedback Integration – Utilize insights gained from beta testing to adapt and evolve our platform to better meet the needs of our users.
The journey ahead is promising, and collaboration is key to our success. We are actively seeking partnerships with oncologists and pharmaceutical companies who are as passionate as we are about transforming cancer therapy and significantly improving patient outcomes.
The road from concept to market is filled with challenges, but with our recent funding and the ongoing support from the medical and scientific community, we are more equipped than ever to tackle these challenges head-on. We invite you to join us on this exciting journey as we push the boundaries of what’s possible in cancer drug discovery.
Interested in learning more about Cymoplive or exploring partnership opportunities? Reach out through the contact form at the bottom of this page or directly to our team on social media via the links on the top right. Together, we can make a meaningful impact in the fight against cancer.